{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:12:26Z","timestamp":1788286346549,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T00:00:00Z","timestamp":1651708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.ypmed.2022.107076","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T03:52:31Z","timestamp":1651809151000},"page":"107076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Modelling the impact of the coronavirus pandemic on bowel cancer screening outcomes in England: A decision analysis to prepare for future screening disruption"],"prefix":"10.1016","volume":"160","author":[{"given":"Olena","family":"Mandrik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Chilcott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ypmed.2022.107076_bb0005","series-title":"One and Five Year Net Survival for Adults Diagnosed between 2013 and 2017","author":"Adult Cancer Survival Tables","year":"2022"},{"key":"10.1016\/j.ypmed.2022.107076_bb0010","author":"Bowel Cancer Incidence Statistics"},{"key":"10.1016\/j.ypmed.2022.107076_bb0015","series-title":"England and Wales: Deaths Occurring between 28 December 2019 and 4 September 2020","author":"Changes in all-Ccause and COVID-19 Mmortality over Ttime","year":"2020"},{"issue":"11","key":"10.1016\/j.ypmed.2022.107076_bb0020","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s40273-020-00937-z","article-title":"Estimating transition probabilities from published evidence: a tutorial for decision modelers","volume":"38","author":"Gidwani","year":"2020","journal-title":"PharmacoEconomics"},{"key":"10.1016\/j.ypmed.2022.107076_bb0025","author":"Health Survey for England"},{"issue":"4","key":"10.1016\/j.ypmed.2022.107076_bb0035","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.6454","article-title":"Model-based estimation of colorectal cancer screening and outcomes during the COVID-19 pandemic","volume":"4","author":"Issaka","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"4","key":"10.1016\/j.ypmed.2022.107076_bb0040","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S2468-1253(21)00003-0","article-title":"Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study","volume":"6","author":"de Jonge","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.ypmed.2022.107076_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2021.106643","article-title":"The national FIT-based colorectal cancer screening program in the Netherlands during the COVID-19 pandemic","volume":"151","author":"Kortlever","year":"2021","journal-title":"Prev. Med."},{"issue":"10","key":"10.1016\/j.ypmed.2022.107076_bb0050","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1136\/gutjnl-2011-300843","article-title":"Outcomes of the bowel cancer screening Programme (BCSP) in England after the first 1 million tests","volume":"61","author":"Logan","year":"2012","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.ypmed.2022.107076_bb0055","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1136\/gutjnl-2020-321650","article-title":"Prioritisation by FIT to mitigate the impact of delays in the 2-week wait colorectal cancer referral pathway during the COVID-19 pandemic: a UK modelling study","volume":"70","author":"Loveday","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.ypmed.2022.107076_bb0060","series-title":"Calibration and Validation of the Microsimulation Model in Cancer of the Bowel (MiMiC-Bowel), an Individual Patient Simulation Model for Investigation of the Cost-Effectiveness of Personalised Screening and Surveillance Strategies","author":"Mandrik","year":"2021"},{"issue":"4","key":"10.1016\/j.ypmed.2022.107076_bb0065","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40273-021-01125-3","article-title":"Calibrating natural history of Cancer models in the presence of data incompatibility: problems and solutions","volume":"40","author":"Mandrik","year":"2022","journal-title":"Pharmacoeconomics"},{"issue":"8","key":"10.1016\/j.ypmed.2022.107076_bb0070","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1470-2045(20)30388-0","article-title":"The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study","volume":"21","author":"Maringe","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ypmed.2022.107076_bb0075","first-page":"1","article-title":"Impact of the COVID-19 pandemic on colorectal cancer screening: a systematic review","author":"Mazidimoradi","year":"2021","journal-title":"J. Gastrointest. Cancer"},{"issue":"9","key":"10.1016\/j.ypmed.2022.107076_bb0080","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1136\/gutjnl-2015-310691","article-title":"Increased uptake and improved outcomes of bowel cancer screening with a faecal immunochemical test: results from a pilot study within the national screening programme in England","volume":"66","author":"Moss","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.ypmed.2022.107076_bb0085","author":"National Schedule of Reference Costs 2017\/18"},{"issue":"2","key":"10.1016\/j.ypmed.2022.107076_bb0090","doi-asserted-by":"crossref","first-page":"433","DOI":"10.14309\/ajg.0000000000000970","article-title":"Colorectal cancer screening and COVID-19","volume":"116","author":"Patel","year":"2021","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.ypmed.2022.107076_bb0030","series-title":"https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/populationandmigration\/populationestimates\/adhocs\/009283populationsbysexagegroupandimdquintileengland2001to2017","article-title":"Populations by Sex, Age Group And Index of Multiple Deprivation (IMD) Quintile, England, 2001 to 2017","year":"2018"},{"key":"10.1016\/j.ypmed.2022.107076_bb0095","series-title":"Appendix D: NHS Bowel Cancer Screening Programme","article-title":"Report of the independent review of adult screening programmes in England","author":"Richards","year":"2019"},{"issue":"8","key":"10.1016\/j.ypmed.2022.107076_bb0100","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S1470-2045(20)30392-2","article-title":"Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study","volume":"21","author":"Sud","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ypmed.2022.107076_bb0105","series-title":"Quantifying and Mitigating the Impact of the COVID-19 Pandemic on Outcomes in Colorectal Cancer","author":"Sud","year":"2020"},{"issue":"8","key":"10.1016\/j.ypmed.2022.107076_bb0110","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S2468-1253(20)30200-4","article-title":"H. Resuming bowel cancer screening post-COVID-19","volume":"5","author":"The Lancet Gastroenterology","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.ypmed.2022.107076_bb0115","series-title":"Development of the Microsimulation Model in Cancer of the Bowel (MiMiC-Bowel), an Individual Patient Simulation Model for Investigation of the Cost-effectiveness of Personalised Screening and Surveillance Strategies","author":"Thomas","year":"2020"},{"issue":"8","key":"10.1016\/j.ypmed.2022.107076_bb0120","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1158\/1940-6207.CAPR-20-0620","article-title":"The costs and benefits of risk stratification for colorectal cancer screening based on phenotypic and genetic risk: a health economic analysis","volume":"14","author":"Thomas","year":"2021","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.ypmed.2022.107076_bb0125","article-title":"Should colorectal cancer screening start at different ages for men and women? Cost-effectiveness analysis for a resource-constrained service","author":"Thomas","year":"2021","journal-title":"Cancer Rep. (Hoboken)"},{"key":"10.1016\/j.ypmed.2022.107076_bb0130","author":"Unit Costs of Health and Social Care 2018"},{"key":"10.1016\/j.ypmed.2022.107076_bb0135","series-title":"Optimising Bowel Cancer Screening Phase 1: Optimising the Cost Effectiveness of Repeated FIT Screening and Screening Strategies Combining Bowel Scope and FIT Screening: ScHARR","author":"Whyte","year":"2017"},{"key":"10.1016\/j.ypmed.2022.107076_bb0140","article-title":"Optimizing the design of a repeated fecal immunochemical test bowel cancer screening programme with a limited endoscopy capacity from a health economic perspective","author":"Whyte","year":"2021","journal-title":"Value Health"}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743522001244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743522001244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T10:15:33Z","timestamp":1758795333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743522001244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":28,"alternative-id":["S0091743522001244"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2022.107076","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modelling the impact of the coronavirus pandemic on bowel cancer screening outcomes in England: A decision analysis to prepare for future screening disruption","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2022.107076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107076"}}